Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				LUC 05-003 NCT00365937


2.		Peptide-Pulsed vs. RNA-Transfected Dendritic Cell Vaccines in Melanoma Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 to 75				Other				2003-2917 KWF 2003-2917, NCT00243529

Last Modified: 1/7/2009 First Published: 10/24/2003


3.		Phase II Randomized Study of Multi-Epitope Vaccination With Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				ECOG-E1602 NCT00071981, E1602

Last Modified: 11/18/2008 First Published: 6/24/2008


4.		Pilot Randomized Study of Vaccine Therapy Comprising Melanoma Multipeptides and Tetanus Toxoid Helper Peptide Emulsified in Incomplete Freund's Adjuvant in Patients With Advanced Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				18 and older				NCI				UVACC-MEL-48 Mel 48, UVACC-IRB-13498, UVACC-PRC-450-07, NCT00705640

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute